Normal and malignant B cells used to identify small RNA transcriptome
| ID . | Sample . | B-cell stage/phenotype . |
|---|---|---|
| S1 | Naive B cell (FACS-sorted primary human) | Naive |
| S2 | Naive B cell (FACS-sorted primary human) | Naive |
| S3 | Germinal center B cell (FACS-sorted primary human) | Germinal center |
| S4 | Germinal center B cell (FACS-sorted primary human) | Germinal center |
| S5 | Memory B cell (FACS-sorted primary human) | Memory |
| S6 | Memory B cell (FACS-sorted primary human) | Memory |
| S7 | Plasma cell (FACS-sorted primary human) | Plasma cell |
| S8 | Plasma cell (FACS-sorted primary human) | Plasma cell |
| S9 | Activated B cell (primary human) | Naive |
| S10 | Epstein-Barr virus–transformed B cell (primary human) | Naive |
| S11 | Lymphoblastic lymphoma (primary human tumor) | Precursor B cell |
| S12 | Transformed follicular lymphoma (primary human tumor) diffuse large B-cell lymphoma | Germinal center |
| S13 | Diffuse large B-cell lymphoma (Farage human cell line) | Germinal center |
| S14 | Diffuse large B-cell lymphoma (BJAB human cell line) | Germinal center |
| S15 | Diffuse Large B-cell lymphoma (LY3 human cell line) | Activated phenotype |
| S16 | Burkitt lymphoma (primary human tumor) | Germinal center |
| S17 | Burkitt lymphoma (Ramos human cell line) | Germinal center |
| S18 | Burkitt lymphoma (Daudi human cell line) | Germinal center |
| S19 | HIV lymphoma (primary human tumor) | Unknown |
| S20 | Mantle cell lymphoma (JVM2 human cell line) | Naive |
| S21 | Mantle cell lymphoma (JVM13 human cell line) | Naive |
| S22 | Mantle cell lymphoma (Mino human cell line) | Naive |
| S23 | Hodkgin lymphoma (L1236 human cell line) | Germinal center |
| S24 | Hodkgin lymphoma (L428 human cell line) | Germinal center |
| S25 | Multiple myeloma (U266 human cell line) | Plasma cell |
| S26 | Multiple myeloma (H929 human cell line) | Plasma cell |
| S27 | Multiple myeloma (KMS12 human cell line) | Plasma cell |
| S28 | Marginal zone lymphoma (primary human tumor) | MALT type |
| S29 | Marginal zone lymphoma (primary human tumor) | Splenic type |
| S30 | Chronic lymphocytic leukemia (primary human tumor) | IgVH mutated phenotype |
| S31 | Chronic lymphocytic leukemia (primary human tumor) | IgVH unmutated phenotype |
| ID . | Sample . | B-cell stage/phenotype . |
|---|---|---|
| S1 | Naive B cell (FACS-sorted primary human) | Naive |
| S2 | Naive B cell (FACS-sorted primary human) | Naive |
| S3 | Germinal center B cell (FACS-sorted primary human) | Germinal center |
| S4 | Germinal center B cell (FACS-sorted primary human) | Germinal center |
| S5 | Memory B cell (FACS-sorted primary human) | Memory |
| S6 | Memory B cell (FACS-sorted primary human) | Memory |
| S7 | Plasma cell (FACS-sorted primary human) | Plasma cell |
| S8 | Plasma cell (FACS-sorted primary human) | Plasma cell |
| S9 | Activated B cell (primary human) | Naive |
| S10 | Epstein-Barr virus–transformed B cell (primary human) | Naive |
| S11 | Lymphoblastic lymphoma (primary human tumor) | Precursor B cell |
| S12 | Transformed follicular lymphoma (primary human tumor) diffuse large B-cell lymphoma | Germinal center |
| S13 | Diffuse large B-cell lymphoma (Farage human cell line) | Germinal center |
| S14 | Diffuse large B-cell lymphoma (BJAB human cell line) | Germinal center |
| S15 | Diffuse Large B-cell lymphoma (LY3 human cell line) | Activated phenotype |
| S16 | Burkitt lymphoma (primary human tumor) | Germinal center |
| S17 | Burkitt lymphoma (Ramos human cell line) | Germinal center |
| S18 | Burkitt lymphoma (Daudi human cell line) | Germinal center |
| S19 | HIV lymphoma (primary human tumor) | Unknown |
| S20 | Mantle cell lymphoma (JVM2 human cell line) | Naive |
| S21 | Mantle cell lymphoma (JVM13 human cell line) | Naive |
| S22 | Mantle cell lymphoma (Mino human cell line) | Naive |
| S23 | Hodkgin lymphoma (L1236 human cell line) | Germinal center |
| S24 | Hodkgin lymphoma (L428 human cell line) | Germinal center |
| S25 | Multiple myeloma (U266 human cell line) | Plasma cell |
| S26 | Multiple myeloma (H929 human cell line) | Plasma cell |
| S27 | Multiple myeloma (KMS12 human cell line) | Plasma cell |
| S28 | Marginal zone lymphoma (primary human tumor) | MALT type |
| S29 | Marginal zone lymphoma (primary human tumor) | Splenic type |
| S30 | Chronic lymphocytic leukemia (primary human tumor) | IgVH mutated phenotype |
| S31 | Chronic lymphocytic leukemia (primary human tumor) | IgVH unmutated phenotype |